70.60
price up icon2.02%   1.40
pre-market  プレマーケット:  71.29   0.69   +0.98%
loading
前日終値:
$69.20
開ける:
$69.8
24時間の取引高:
3.00M
Relative Volume:
0.69
時価総額:
$41.45B
収益:
$5.72B
当期純損益:
$4.17B
株価収益率:
10.13
EPS:
6.97
ネットキャッシュフロー:
$259.90M
1週間 パフォーマンス:
-0.23%
1か月 パフォーマンス:
+0.20%
6か月 パフォーマンス:
+1.96%
1年 パフォーマンス:
-18.81%
1日の値動き範囲:
Value
$69.21
$70.79
1週間の範囲:
Value
$68.63
$72.15
52週間の値動き範囲:
Value
$58.93
$95.25

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
名前
Edwards Lifesciences Corp
Name
セクター
Healthcare (1153)
Name
電話
(949) 250-2500
Name
住所
ONE EDWARDS WAY, IRVINE, CA
Name
職員
15,800
Name
Twitter
@edwardslifesci
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
EW's Discussions on Twitter

EW を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-30 アップグレード Stifel Hold → Buy
2025-01-16 ダウングレード Wolfe Research Peer Perform → Underperform
2024-12-16 アップグレード BofA Securities Neutral → Buy
2024-10-11 再開されました Morgan Stanley Equal-Weight
2024-09-18 ダウングレード Jefferies Buy → Hold
2024-07-31 アップグレード Daiwa Securities Neutral → Outperform
2024-07-29 アップグレード Wolfe Research Underperform → Peer Perform
2024-07-25 ダウングレード BofA Securities Buy → Neutral
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-07-25 ダウングレード Robert W. Baird Outperform → Neutral
2024-07-25 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード Truist Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-05-22 アップグレード Citigroup Neutral → Buy
2024-05-14 アップグレード Deutsche Bank Hold → Buy
2024-03-07 アップグレード BofA Securities Neutral → Buy
2024-02-02 アップグレード Wells Fargo Equal Weight → Overweight
2024-01-04 ダウングレード Evercore ISI Outperform → In-line
2023-12-11 ダウングレード Citigroup Buy → Neutral
2023-11-28 ダウングレード Wolfe Research Peer Perform → Underperform
2023-09-26 アップグレード Oppenheimer Perform → Outperform
2023-07-19 開始されました Robert W. Baird Outperform
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Neutral
2023-03-08 ダウングレード Wells Fargo Overweight → Equal Weight
2023-02-06 ダウングレード Raymond James Outperform → Mkt Perform
2023-01-31 ダウングレード Bernstein Outperform → Underperform
2023-01-30 ダウングレード Piper Sandler Overweight → Neutral
2022-12-06 ダウングレード Stifel Buy → Hold
2022-10-28 ダウングレード Oppenheimer Outperform → Perform
2022-10-26 開始されました Mizuho Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-29 ダウングレード Canaccord Genuity Buy → Hold
2022-04-13 開始されました Truist Buy
2022-04-06 開始されました Wolfe Research Outperform
2022-03-16 アップグレード Bernstein Mkt Perform → Outperform
2022-03-02 再開されました BofA Securities Neutral
2022-02-02 アップグレード UBS Neutral → Buy
2022-01-27 繰り返されました Citigroup Buy
2022-01-27 繰り返されました Evercore ISI Outperform
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました Stifel Buy
2022-01-27 繰り返されました UBS Neutral
2021-12-17 アップグレード JP Morgan Neutral → Overweight
2021-12-15 アップグレード Citigroup Neutral → Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-12-06 アップグレード Wells Fargo Equal Weight → Overweight
2021-07-30 繰り返されました Canaccord Genuity Buy
2021-07-30 繰り返されました Deutsche Bank Hold
2021-07-30 繰り返されました Jefferies Buy
2021-07-30 繰り返されました Morgan Stanley Overweight
2021-07-30 繰り返されました Oppenheimer Outperform
2021-07-30 繰り返されました Stifel Buy
2021-07-30 繰り返されました UBS Neutral
2021-07-30 繰り返されました Wells Fargo Equal Weight
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-04-05 アップグレード Evercore ISI In-line → Outperform
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-12-11 繰り返されました Canaccord Genuity Buy
2020-09-11 開始されました Wolfe Research Underperform
2020-04-28 ダウングレード Wells Fargo Overweight → Equal Weight
2020-04-17 アップグレード SVB Leerink Mkt Perform → Outperform
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-10 開始されました Oppenheimer Outperform
2020-01-02 ダウングレード Evercore ISI Outperform → In-line
2019-10-24 繰り返されました Canaccord Genuity Buy
2019-09-23 開始されました Piper Jaffray Overweight
2019-07-24 繰り返されました BofA/Merrill Buy
2019-03-18 繰り返されました Canaccord Genuity Buy
2019-01-18 アップグレード BofA/Merrill Neutral → Buy
2019-01-03 開始されました Deutsche Bank Hold
2018-11-28 開始されました UBS Neutral
2018-10-16 開始されました Barclays Underweight
2018-10-02 ダウングレード BofA/Merrill Buy → Neutral
2018-10-02 ダウングレード Guggenheim Buy → Neutral
すべてを表示

Edwards Lifesciences Corp (EW) 最新ニュース

pulisher
Apr 18, 2025

Edwards touts 8-year data for Resilia valve tissue - MassDevice

Apr 18, 2025
pulisher
Apr 18, 2025

Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance

Apr 18, 2025
pulisher
Apr 18, 2025

Edwards Lifesciences (EW) Shares Surge on Promising Aortic Valve Study Results | EW Stock News - GuruFocus

Apr 18, 2025
pulisher
Apr 18, 2025

Breakthrough: Edwards Heart Valves Achieve 99.3% Success Rate in Landmark 8-Year Study - Stock Titan

Apr 18, 2025
pulisher
Apr 17, 2025

Is Edwards Lifesciences Gaining or Losing Market Support? - Benzinga

Apr 17, 2025
pulisher
Apr 17, 2025

Solid TMTT Growth to Drive Edwards Lifesciences' Q1 Earnings - MSN

Apr 17, 2025
pulisher
Apr 16, 2025

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025 - marketscreener.com

Apr 16, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences Insider Sold Shares Worth $663,196, According to a Recent SEC Filing - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences CVP Donald Bobo Jr. sells $663k in stock - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Edwards Lifesciences (EW) Secures CE Mark for Innovative Mitral Valve System | EW Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 14, 2025

Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System - BioSpace

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Lifesciences CVP Donald Bobo Jr. sells $663k in stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards lands first CE mark for transfemoral mitral valve replacement - BioWorld MedTech

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Lifesciences Gets CE Mark for Sapien M3 Mitral Valve System - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards Sapien M3 Receives CE Mark, Becoming World'S First Transfemoral Transcatheter Mitral Valve Replacement System - MarketScreener

Apr 14, 2025
pulisher
Apr 14, 2025

Edwards wins CE mark for Sapien M3 transfemoral heart valve - MassDevice

Apr 14, 2025
pulisher
Apr 14, 2025

Breakthrough: First-Ever Transcatheter Mitral Valve Replacement Gets CE Mark Approval - Stock Titan

Apr 14, 2025
pulisher
Apr 13, 2025

Investors in Edwards Lifesciences Corporation Should Contact Levi & Korsinsky Before December 13, 2024 to Discuss Your RightsEW - marketscreener.com

Apr 13, 2025
pulisher
Apr 11, 2025

Edwards Lifesciences Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga

Apr 11, 2025
pulisher
Apr 11, 2025

Truist Cuts Price Target on Edwards Lifesciences to $75 From $78, Keeps Hold Rating - marketscreener.com

Apr 11, 2025
pulisher
Apr 10, 2025

Edwards Lifesciences’ Quarterly Earnings Preview: What You Need to Know - Nasdaq

Apr 10, 2025
pulisher
Apr 10, 2025

Edwards Lifesciences’ Quarterly Earnings Preview: What You Need To Know - Barchart.com

Apr 10, 2025
pulisher
Apr 09, 2025

Edwards lifesciences CVP Daniel Lippis sells $21,183 in stock By Investing.com - Investing.com Canada

Apr 09, 2025
pulisher
Apr 08, 2025

Edwards lifesciences CVP Daniel Lippis sells $21,183 in stock - Investing.com

Apr 08, 2025
pulisher
Apr 07, 2025

CMS rolls out draft coverage memo for TEER for the tricuspid valve - BioWorld MedTech

Apr 07, 2025
pulisher
Apr 07, 2025

Citigroup Adjusts Edwards Lifesciences Price Target to $84 From $83, Maintains Buy Rating - MarketScreener

Apr 07, 2025
pulisher
Apr 04, 2025

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry - Benzinga

Apr 04, 2025
pulisher
Apr 03, 2025

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Apr 03, 2025
pulisher
Apr 03, 2025

Medical Device Industry: Swept Up in the Tariffs, Diabetes Device Makers Bear the Brunt - Morningstar

Apr 03, 2025
pulisher
Apr 01, 2025

Edwards Lifesciences (NYSE:EW) Presents Promising AS Treatment Data At ACC Session - Yahoo Finance

Apr 01, 2025
pulisher
Apr 01, 2025

Edwards’ Early TAVR refutes surveillance recs for aortic stenosis - BioWorld MedTech

Apr 01, 2025
pulisher
Apr 01, 2025

Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities - Yahoo Home

Apr 01, 2025
pulisher
Mar 31, 2025

Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now! - Insider Monkey

Mar 31, 2025
pulisher
Mar 31, 2025

Edwards shares data supporting timely TAVR intervention - MassDevice

Mar 31, 2025
pulisher
Mar 27, 2025

Huntington Beach man meets heart valve engineers who saved his life - Los Angeles Times

Mar 27, 2025
pulisher
Mar 27, 2025

Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $85 From $92, Keeps Buy Rating - MarketScreener

Mar 27, 2025
pulisher
Mar 27, 2025

Goldman Sachs Adjusts Price Target to Edwards Lifesciences to $85 From $92, Keeps Buy Rating - MarketScreener

Mar 27, 2025
pulisher
Mar 26, 2025

Edwards Lifesciences CFO Scott Ullem sells $797,267 in stock - Investing.com

Mar 26, 2025
pulisher
Mar 26, 2025

Edwards Lifesciences CFO Scott Ullem sells $797,267 in stock By Investing.com - Investing.com South Africa

Mar 26, 2025
pulisher
Mar 23, 2025

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead - Seeking Alpha

Mar 23, 2025
pulisher
Mar 18, 2025

S&P 500 Gains and Losses Today: Edwards Lifesciences Sinks on Outlook for Key Product - MSN

Mar 18, 2025
pulisher
Mar 17, 2025

How Is The Market Feeling About Edwards Lifesciences? - Benzinga

Mar 17, 2025
pulisher
Mar 17, 2025

Is Edwards Lifesciences Stock Underperforming the Nasdaq? - Nasdaq

Mar 17, 2025
pulisher
Mar 17, 2025

Is Edwards Lifesciences Stock Underperforming The Nasdaq? - Barchart

Mar 17, 2025
pulisher
Mar 14, 2025

Edwards Lifesciences downgraded at JPM, Truist on slower transcatheter valve growth - MSN

Mar 14, 2025
pulisher
Mar 13, 2025

Edwards Lifesciences VP Donald Bobo Jr. sells $645,623 in stock By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

Edwards Lifesciences VP Donald Bobo Jr. sells $645,623 in stock - Investing.com

Mar 13, 2025

Edwards Lifesciences Corp (EW) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$61.65
price up icon 1.93%
$66.33
price up icon 0.33%
medical_devices STE
$222.77
price up icon 1.82%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices ZBH
$97.44
price up icon 1.32%
大文字化:     |  ボリューム (24 時間):